Meropenem pseudomonas searching
Top keyword related from Search Engine of meropenem pseudomonas
meropenem pseudomonas
meropenem pseudomonas coverage
meropenem pseudomonas aeruginosa
meropenem pseudomonas dosing
meropenem pseudomonas mic
does meropenem cover pseudomonas
meropenem resistant pseudomonas
meropenem cover pseudomonas
meropenem resistant pseudomonas aeruginosa
ertapenem vs meropenem pseudomonas
meropenem and pseudomonas coverage
Top URL related to meropenem pseudomonas
-
1. Principles of antimicrobial therapy of Pseudomonas ... - UpToDate
uptodate.com
Link: https://www.uptodate.com/contents/principles-of-antimicrobial-therapy-of-pseudomonas-aeruginosa-infections
Description: WebFeb 6, 2024 · Pseudomonas aeruginosa is a key gram-negative aerobic bacillus in the differential diagnosis of a number of infections. This organism is important because it is often antibiotic resistant and can cause severe hospital-acquired infections associated with a high mortality rate, especially in immunocompromised hosts.
-
2. IDSA 2023 Guidance on the Treatment of Antimicrobial Resistant …
idsociety.org
Link: https://www.idsociety.org/practice-guideline/amr-guidance/
Description: WebSuggested approach: Meropenem, imipenem-cilastatin, or ertapenem are preferred for the treatment of infections outside of the urinary tract caused by ESBL-E. For patients who are critically ill and/or experiencing hypoalbuminemia, meropenem or imipenem-cilastatin are the preferred carbapenems.
-
3. Evidence-Based Treatment of Pseudomonas aeruginosa …
nih.gov
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952410/
Description: WebFeb 16, 2023 · Meropenem-vaborbactam is a carbapenem/non-beta-lactam beta-lactamase inhibitor combination showing activities similar to simple meropenem in P. aeruginosa infections, as meropenem resistance in P. aeruginosa is mostly a result of mechanisms not impacted by vaborbactam.
-
4. Anti-Infective Dosing Protocols: Meropenem, Cefepime, and …
nebraskamed.com
Link: https://www.nebraskamed.com/sites/default/files/documents/for-providers/asp/Dosing-Protocol-RPeducation.pdf
Description: Websputum isolates growing Pseudomonas aeruginosa were evaluated, and MICs were obtained via Sensititre susceptibility plates. Susceptible MIC (mg/L) MIC 50 (mg/L) MIC 90 (mg/L) Meropenem ≤ 1 ≤ 1 4 Cefepime ≤ 8 8 16 Piperacillin/tazobactam ≤ 64 8 ≥ 64 MIC50 = MIC needed to inhibit the growth of 50% of the isolates
-
5. New Drugs for the Treatment of Pseudomonas aeruginosa …
nih.gov
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137685/
Description: WebApr 26, 2022 · Meropenem-vaborbactam is an antimicrobial combination of a well-known, broad spectrum carbapenem and a novel cyclic boronic acid β-lactamase inhibitor with a high affinity of serine residues which enables it to perform as a competitive inhibitor by forming a covalent bond with the β-lactamase without undergoing hydrolysis .
-
6. Medication Administration: Extended-Infusion Meropenem …
stanford.edu
Link: https://med.stanford.edu/content/dam/sm/bugsanddrugs/documents/antimicrobial-dosing-protocols/SHC-Extended-Infusion-Meropenem.pdf
Description: WebMeropenem belongs to the antibiotic class of carbapenems, which are known to be broad-spectrum antibiotics effective against several drug-resistant organisms. Notably, meropenem remains a viable option with efficacy against extended-spectrum beta-lactamase (ESBL)-producing organisms and Pseudomonas aeruginosa.
-
7. Dosage Regimens for Meropenem in Children with Pseudomonas …
nih.gov
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070814/
Description: WebNov 20, 2019 · Dosage Regimens for Meropenem in Children with Pseudomonas Infections Do Not Meet Serum Concentration Targets - PMC. Journal List. Clin Transl Sci. v.13 (2); 2020 Mar. PMC7070814. As a library, NLM provides access to scientific literature.
-
8. Update on the Efficacy and Tolerability of Meropenem in the …
oup.com
Link: https://academic.oup.com/cid/article/47/Supplement_1/S41/305563
Description: WebSep 15, 2008 · Meropenem is a carbapenem antibiotic approved by the US Food and Drug Administration for the treatment of complicated skin and skin-structure infections, complicated intra-abdominal infections, and pediatric bacterial meningitis (in patients ⩾3 months of age).
-
9. Pseudomonas aeruginosa Infections Medication: Antibiotics - Medscape
medscape.com
Link: https://emedicine.medscape.com/article/226748-medication
Description: WebMar 3, 2023 · With the exception of cases involving febrile patients with neutropenia, in whom monotherapy with ceftazidime or a carbapenem (eg, imipenem, meropenem) is used, a 2-drug regimen is recommended....
-
10. Antibacterial activity of meropenem against Pseudomonas ... - PubMed
nih.gov
Link: https://pubmed.ncbi.nlm.nih.gov/9923514/
Description: WebAbstract. The in vitro effects of meropenem on Pseudomonas aeruginosa were examined by studying (i) the inhibitory and bactericidal concentrations of meropenem versus those of imipenem for clinical isolates; (ii) changes in bacterial morphology during in vitro culture; and (iii) release of endotoxin induced by meropenem compared with that ...